You are here: All Products  > Chengdu's HitGen Licenses Cancer Drug Candidates to Cancer Research UK

Chengdu's HitGen Licenses Cancer Drug Candidates to Cancer Research UK

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products